LyophilisedTIPA
Tesamorelin + Ipamorelin Combination
Bulk≥99.5% Purity
Pre-combined Tesamorelin + Ipamorelin for enhanced growth hormone release with body composition benefits.
Request a Quote
Pricing available for qualified medical professionals, clinics, and distributors.
Enquire NowDownload MonographView FAQMechanism of Action
Combines Tesamorelin (GHRH analogue) and Ipamorelin (selective GHS) for dual-pathway GH stimulation. Tesamorelin provides strong GHRH receptor activation with visceral fat-reducing properties, while Ipamorelin adds selective ghrelin receptor activation without cortisol or prolactin side effects.
Clinical Benefits
- Dual GHRH + GHS mechanism for enhanced GH release
- Tesamorelin-driven visceral fat reduction
- Ipamorelin selectivity minimises side effects
- Optimised ratio for clinical protocols
Specifications
ComponentsTesamorelin + Ipamorelin
MechanismGHRH + GHS dual pathway
Purity≥99.5% (each component)
Storage & Handling
- Store at -20°C
- Reconstituted: 2–8°C
- Protect from light
For professional medical use only. Not for retail sale to the general public. Pricing available on request for qualified medical institutions and distributors.